Dilek Kaan | Stem Cell | Best Researcher Award

Posted on by Skincare

Best Researcher Award

Dilek Kaan
Affiliation Erciyes University
Country Turkey
Scopus ID 57189595553
Documents 4
Citations 48
h-index 2
Subject Area Stem Cell
Event World Skincare Innovation Awards
ORCID 0000-0003-3622-2249

Dilek Kaan
Erciyes University

Dilek Kaan is a researcher associated with Erciyes University whose scholarly work has focused primarily on stem cell studies, cellular biology, extracellular vesicles, and molecular investigations related to disease mechanisms. Research records indexed through ORCID and Scopus indicate contributions within laboratory and translational biomedical studies that explore cellular behavior and experimental biological systems.[1]

Abstract

This article summarizes academic activities, publication records, and research characteristics associated with Dilek Kaan. Available indexed records indicate involvement in studies related to stem cell biology and molecular investigations, including extracellular vesicles and cellular signaling mechanisms. The article also presents publication references and research indicators relevant to academic recognition assessment.[2]

Keywords

Stem cell biology, extracellular vesicles, apoptosis, molecular biology, translational medicine, biomedical research, cellular mechanisms.

Introduction

Biomedical research increasingly depends on molecular approaches that clarify mechanisms of disease and cellular regulation. Investigations involving stem cells and associated biological pathways support the development of translational understanding in medicine. Published work associated with Dilek Kaan reflects participation in this broader scientific environment.[3]

Research Profile

Research activities associated with Dilek Kaan reflect interdisciplinary work in molecular biology, stem cell science, and experimental biomedical research. Available indexed author records indicate continuing involvement in studies related to cellular mechanisms and laboratory-based scientific investigations. Research efforts have focused on understanding biological pathways and molecular responses associated with disease conditions and experimental models. The profile also demonstrates participation in research themes that integrate translational and cellular perspectives within modern biomedical sciences.[4]

Research Contributions

Research contributions include studies involving stem cell lines, extracellular vesicles, apoptosis mechanisms, and molecular biomarker analysis. Published findings contribute toward understanding cellular responses and biological interactions observed under different experimental conditions. Research outcomes may support future investigations involving translational medicine and laboratory applications. These activities collectively indicate a continuing contribution toward biomedical and molecular research development.[5]

Publications

Published work associated with Dilek Kaan includes investigations related to mesenchymal stem cell exosomes, molecular biology, extracellular vesicle isolation, and disease-associated cellular processes. Several studies evaluate biological responses and experimental cellular mechanisms within laboratory environments. Publication records also indicate research on gene expression and apoptosis pathways. These studies collectively reflect consistency in scientific themes across multiple biomedical contexts.[1]

Research Impact

Citation indicators and indexed publication activity provide measurable information regarding scholarly dissemination and academic visibility. Bibliometric indicators are frequently used as supporting measures when evaluating scientific engagement and research reach. Research influence is commonly interpreted together with publication quality and collaboration activity. Such indicators contribute to understanding the broader academic significance of published scientific work.

Award Suitability

Evaluation for research recognition generally considers publication quality, research consistency, scholarly productivity, and scientific contributions. Available publication records and indexed research metrics indicate continuing participation within biomedical investigations. Research themes associated with stem cell science and molecular studies align with current scientific interests. These characteristics may support consideration within academic recognition frameworks.

Conclusion

Academic profiles integrate publication history, collaborative work, and scientific output into a broader perspective of scholarly activity. Available records associated with Dilek Kaan indicate continuing research engagement involving molecular biology and stem cell investigations. Publication themes demonstrate consistency across experimental biomedical studies and laboratory-based research environments. The profile therefore reflects an active contribution within contemporary scientific research areas.

References

  1. Kaan, D. (2022). Expression and biochemical significance of Piwil2 in stem cell lines. Postępy Higieny i Medycyny Doświadczalnej.
    https://doi.org/10.2478/ahem-2022-0009
  2. Kaan, D. (2023). Adipoz Doku Kaynaklı Ekstrasellüler Veziküllerin Meme Kanseri Hücreleri Üzerine Apoptotik Etkisi. Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi.
    https://doi.org/10.21597/jist.1213841
  3. Kaan, D. (2023). Wharton Jel Kaynaklı Eksozom İzolasyonu: Metot Karşılaştırma Çalışması. Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi.
    https://doi.org/10.21597/jist.1200996
  4. Şengül, A., Kaan, D., & Güler, H. (2026). Evaluation of Individual Effects of Melatonin and Mesenchymal Stem Cell Exosomes. Current Issues in Molecular Biology.
    https://doi.org/10.3390/cimb48060623
  5. Eciroglu, H., Şener, E.F., Öztop, D.B., Özmen, S., Kaan, D., & Özkul, Y. (2022). The relationship of learning and memory dysfunction with NEURL1 and RGS14 genes in autism spectrum disorders. Acta Medica Alanya.
    https://doi.org/10.30565/medalanya.1136820

Anastasia Orekhova | Fungal Infection | Young Scientist Award

Posted on by Skincare

Young Scientist Award

Anastasia Orekhova – National Medical Research Center for Therapy and Preventive Medicine

Anastasia Orekhova
Affiliation National Medical Research Center for Therapy and Preventive Medicine
Country Russia
Scopus ID 57201123629
Documents 115
Citations 128
h-index 7
Subject Area Fungal Infection
Event World Skincare Innovation Awards
ORCID 0000-0001-5887-2563

Anastasia Orekhova is a researcher whose scholarly activities focus on fungal infections, microbial biology, and the development of innovative approaches for antifungal treatment and diagnostic applications. Her academic record reflects sustained contributions to microbiology and biomedical sciences, particularly in studies involving Aspergillus species, Candida-related investigations, and nanoparticle-assisted therapeutic strategies.[1]

Abstract

This article presents an overview of Anastasia Orekhova’s scientific profile and research achievements in fungal infection studies. Her work encompasses pathogen biology, antifungal compounds, nanoparticle delivery systems, and diagnostic methodologies relevant to microbiological research. Through peer-reviewed publications and collaborative investigations, she has contributed to the advancement of knowledge concerning medically significant fungi and related therapeutic approaches.[2]

Keywords

Fungal Infection, Microbiology, Aspergillus, Candida, Antifungal Therapy, Nanoparticles, Biomedical Research, Diagnostic Applications.

Introduction

Research involving fungal pathogens has become increasingly important due to the clinical burden associated with invasive and opportunistic infections. Anastasia Orekhova’s studies have focused on understanding fungal mechanisms and evaluating novel strategies for treatment and detection. Her multidisciplinary research integrates microbiology, molecular science, and biomedical innovation to address challenges associated with fungal diseases.[3]

Research Profile

According to publicly available academic profiles, Orekhova has been associated with research institutions in Russia and Italy and has participated in studies related to infectious diseases and microbiology. Her scholarly output includes articles indexed in international databases and contributions addressing fungal physiology, extracellular enzymes, and therapeutic technologies.[1]

Research Contributions

  • Investigation of nanoparticle-based antifungal delivery systems.
  • Research on Aspergillus proteases and their biological activity.
  • Studies evaluating anti-Candida compounds and natural products.
  • Development of methodologies relevant to plasma protein analysis and fungal diagnostics.

Publications

Selected publications include investigations on Botrytis cinerea control through nanoparticle vectors, Aspergillus-targeted antifungal formulations, extracellular fungal proteases, and anti-Candida activity assessments. These studies have appeared in journals such as Scientific Reports, Molecules, Life, Natural Product Research, and Moscow University Biological Sciences Bulletin.[2]

Research Impact

The research portfolio demonstrates measurable scholarly engagement through indexed publications, citations, and interdisciplinary collaborations. Her investigations contribute to the broader understanding of fungal pathogenesis and support the development of evidence-based therapeutic and diagnostic approaches. Such contributions are relevant to both academic research and potential clinical applications.[4]

Award Suitability

Based on her documented publication record, research productivity, and contributions to fungal infection studies, Anastasia Orekhova demonstrates characteristics commonly associated with emerging scientific leadership. Her involvement in innovative investigations and peer-reviewed scholarship aligns with the objectives of the Young Scientist Award presented through the World Skincare Innovation Awards platform.[5]

Conclusion

Anastasia Orekhova has established a research profile centered on fungal microbiology and biomedical innovation. Through studies involving antifungal agents, nanoparticle technologies, and diagnostic methodologies, she has contributed to scientific understanding within her field. Her academic activities provide a foundation for continued research and recognition within the international scientific community.

References

  1. De Angelis, G., Simonetti, G., Chronopoulou, L., Orekhova, A., Badiali, C., Petruccelli, V., Portoghesi, F., D’Angeli, S., Brasili, E., & Pasqua, G. (2022). A novel approach to control Botrytis cinerea fungal infections: Uptake and biological activity of antifungals encapsulated in nanoparticle-based vectors. Scientific Reports, 12, Article 7286.
    https://doi.org/10.1038/s41598-022-11533-w
  2. Orekhova, A., Palocci, C., Chronopoulou, L., De Angelis, G., Badiali, C., Petruccelli, V., D’Angeli, S., Pasqua, G., & Simonetti, G. (2022). Poly-(lactic-co-glycolic) acid nanoparticles entrapping pterostilbene for targeting Aspergillus section Nigri. Molecules, 27(17), 5424.
    https://doi.org/10.3390/molecules27175424
  3. Osmolovskiy, A. A., Schmidt, L., Orekhova, A. V., Komarevtsev, S. K., Kreyer, V. G., Shabunin, S. V., & Egorov, N. S. (2021). Action of extracellular proteases of Aspergillus flavus and Aspergillus ochraceus micromycetes on plasma hemostasis proteins. Life, 11(8), 782.
    https://doi.org/10.3390/life11080782
  4. Cairone, F., Simonetti, G., Orekhova, A., Casadei, M. A., Zengin, G., & Cesa, S. (2021). Health potential of Clery strawberries: Enzymatic inhibition and anti-Candida activity evaluation. Molecules, 26(6), 1731.
    https://doi.org/10.3390/molecules26061731
  5. De Vita, D., Messore, A., Toniolo, C., Frezza, C., Scipione, L., Bertea, C. M., Micera, M., Di Sarno, V., Madia, V. N., Pindinello, I., & Orekhova, A. (2021). Towards a new application of amaranth seed oil as an agent against Candida albicans. Natural Product Research, 35(24), 5758–5762.
    https://doi.org/10.1080/14786419.2019.1696335

Hui Xiong | Pharmaceutics | Best Researcher Award

Posted on by Skincare

Dr. Hui Xiong | Pharmaceutics | Best Researcher Award
Associate Professor | China Pharmaceutical University | China

Dr. Hui Xiong is an Associate Professor in the Department of Pharmaceutics at China Pharmaceutical University, where she leads pioneering research in advanced drug delivery systems and nanomedicine engineering. She earned her Ph.D. in Pharmaceutics and has since focused her career on the rational design of multifunctional nanocarriers to improve the bioavailability, targeting precision, and therapeutic index of anticancer drugs. Her work integrates pharmaceutics, tumor biology, and materials science to develop innovative delivery platforms for combination therapy, pH-activated antiangiogenic chemotherapy, tumor microenvironment modulation, and ferroptosis-inducing therapeutic strategies, with a strong emphasis on breast and pancreatic cancer treatment. Dr. Xiong has published over 30 SCI papers as first or corresponding author in leading journals such as ACS Nano, Nano Letters, Journal of Controlled Release, Small, and Advanced Healthcare Materials, accumulating a total impact factor exceeding 188 and an H-index of 16. Her contributions include groundbreaking studies on vascular normalization, metabolic symbiosis-blocking nanocombinations, bioengineered nanospores for macrophage modulation, and redox-regulated nanodrugs, several of which have been featured on journal covers. She has been the principal investigator for multiple National Natural Science Foundation of China projects and holds four national invention patents, advancing translational pharmaceutics for clinical oncology. Recognized for her contributions to cancer nanomedicine, she also serves as a peer reviewer for several high-impact journals, further shaping the direction of pharmaceutics and targeted drug delivery research. 

Profile : ORCID

Publications

1. He, Z., Wang, R., Qi, Y., Liu, Y., Xiong, H.*, & Yao, J. (2024). Nanocoated bacteria with H₂S generation-triggered self-amplified photothermal and photodynamic effect for breast cancer therapy. Journal of Controlled Release.

2. Qiao, J., Liu, S., Huang, Y., Zhu, X., Xue, C., Wang, Y., Xiong, H.*, & Yao, J. (2024). Glycolysis–noncanonical glutamine dual-metabolism regulation nanodrug enhanced the phototherapy effect for pancreatic ductal adenocarcinoma treatment. Journal of Colloid and Interface Science.

3. Yao, L., Zhu, X., Shan, Y., Zhang, L., Yao, J., & Xiong, H.* (2024). Recent progress in anti-tumor nanodrugs based on tumor microenvironment redox regulation. Small.

4. Shang, Y., Lu, H., Liao, L., Li, S., Xiong, H.*, & Yao, J. (2023). Bioengineered nanospores selectively blocking LC3-associated phagocytosis in tumor-associated macrophages potentiate antitumor immunity. ACS Nano.

5. Xiong, H., Liu, X., Xie, Z., Zhu, L., Lu, H., Wang, C., & Yao, J. (2022). Metabolic symbiosis-blocking nanocombination for tumor vascular normalization treatment. Advanced Healthcare Materials.